Turning Point Shares Rise on Surging Demand for Modern Oral Smokeless Tobacco

Dow Jones
07 May
 

By Rob Curran

 

Shares of Turning Points Brands were higher after surging demand for its Modern Oral smokeless tobacco generated robust quarterly sales growth and caused it to boost sales projections for the brand.

The maker of Zig-Zag rolling papers, Stoker's smokeless tobacco and Solace e-cigarettes logged earnings of $14.4 million, or 79 cents a share, up from $12 million, or 63 cents a share, a year earlier.

Stripping out certain one-off items, first-quarter adjusted earnings amounted to 91 cents a share, in line with the mean analyst estimate, as per FactSet.

Sales rose 28% to $106.4 million, handily beating the average Wall Street target of $95.8 million. Sales of Stoker's smokeless tobacco surged 63%, driven by strong demand for Modern Oral products. Sales of the Modern Oral brand rose almost tenfold to $22.3 million. Smokeless tobacco is growing in popularity with young people in the U.S. and overseas.

Turning Point boosted its projection for 2025 Modern Oral sales to a range between $80 million and $95 million from a prior projection of $60 million to $80 million.

Shares of Turning Point rose 9.3% to $70.90 in premarket trading.

The company backed its prior projection for adjusted earnings before interest, taxes, depreciation and amortization of $108 million to $113 million.

 

Write to Rob Curran at rob.curran@wsj.com

 

(END) Dow Jones Newswires

May 07, 2025 09:13 ET (13:13 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10